Viewing StudyNCT00436423



Ignite Creation Date: 2024-05-05 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00436423
Status: COMPLETED
Last Update Posted: 2007-11-01
First Post: 2007-02-16

Brief Title: A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Sponsor:
Organization: Korea University Anam Hospital

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 38
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: